AbbeLight
Paris
About AbbeLight
Abbelight offers innovative solutions in the field of super-resolution microscopy (nanoscopy) and membrane imaging for biological research. The company's single molecule localization microscopy is a combination of consumable, hardware and software techniques to achieve reliable state-of-the-art science, enabling companies conducting research in the fields of biology, pharmacology and environment to implement super-resolved fluorescence microscopy approaches to observe biological samples with better resolution. Abbelight ambitions to make these cutting-edge techniques accessible to all laboratories by simplifying their use, without sacrificing the performance of instruments. To accomplish this, they accompany scientists from the preparation of the samples to the treatment of the results by proposing chemistry, computer science and optical instruments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2026)
- Website: abbelight.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/abbelight-99451 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.